Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 6, 2002, Pages 789-794

  Mehta, J L ^a   Li, D Y ^a   Yang, H ^a   Raizada, M K ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Angiotensin II; Losartan; Plasminogen activator inibitor 1

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II [3-8]; LOSARTAN; MALONALDEHYDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANIMALS; CATTLE; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER;

EID: 0036100587     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200206000-00003     Document Type: Article

References (26)

1. Molecular biology of angiotensin receptor: Target for drug research?
2. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
4. Randomized trial of losartan versus captopril in patients over 65 with heart failure
5. Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension
6. Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
7. Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
8. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome
9. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
10. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: A potential link between the reninangiotensin system and thrombosis
11. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
12. Stimulation of plasminogen activator inhibitor (PAI-1) in vivo by infusion of angiotensin II: Evidence of potential interaction between the renin-angiotensin system and fibrinolytic function
13. c-src expression
14. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension
15. Ox-LDL enhances anoxiareoxygenation-mediated apoptosis in human coronary endothelial cells: Role of PKC, PTK, Bcl-2 and Fas
16. Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells
17. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis
18. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
19. Pathogenesis of acute myocardial infarction: Novel regulatory systems of bioactive substances in the vessel wall
20. Endothelial dysfunction impaired endogenous fibrinolysis and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction
21. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure
22. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans
23. Inhibition of arterial thrombogenesis by quinapril but not losartan
24. Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes
25. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress
26. Proapoptotic effects of Ang II in human coronary artery endothelial cells: Role of AT1 receptor and PKC activation